Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

Biocon Biologics Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE™ (bevacizumab-nwgd), a ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

Biocon’s share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company’s seventh USFDA ...

Biocon stock ended 4% higher at Rs 317.60 on Friday against the previous close of Rs 305.20 on BSE. The stock touched an ...

Biocon Biologics CEO and managing director Shreehas Tambe stated: “The US FDA approval of Jobevne (bevacizumab-nwgd) is a ...

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received ...

Biocon Biologics' Jobevne, a biosimilar of Avastin, approved by the FDA, expanding oncology portfolio and access to ...

Biocon's stock price increased almost 4 per cent in the early trading session on 11 April after the company’s subsidiary ...

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its receptors.

Key stocks to watch in today’s trade include shares of TCS, Accenture, Deloitte, Tata Steel, BHEL Sun Pharma, Bharti Hexacom ...

Indian stock market could open on a positive note today (Friday, April 11), as indicated by Gift Nifty. At 7:45 AM, Gift ...